DK0518468T3 - Melatoninholdige sammensætninger - Google Patents

Melatoninholdige sammensætninger

Info

Publication number
DK0518468T3
DK0518468T3 DK92303674T DK92303674T DK0518468T3 DK 0518468 T3 DK0518468 T3 DK 0518468T3 DK 92303674 T DK92303674 T DK 92303674T DK 92303674 T DK92303674 T DK 92303674T DK 0518468 T3 DK0518468 T3 DK 0518468T3
Authority
DK
Denmark
Prior art keywords
melatonin
profile
diluent
coating
combination
Prior art date
Application number
DK92303674T
Other languages
English (en)
Inventor
Nava Zisapel
Original Assignee
Neurim Pharma 1991
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24802245&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0518468(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Neurim Pharma 1991 filed Critical Neurim Pharma 1991
Application granted granted Critical
Publication of DK0518468T3 publication Critical patent/DK0518468T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
DK92303674T 1991-05-09 1992-04-23 Melatoninholdige sammensætninger DK0518468T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69771491A 1991-05-09 1991-05-09

Publications (1)

Publication Number Publication Date
DK0518468T3 true DK0518468T3 (da) 2000-01-31

Family

ID=24802245

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92303674T DK0518468T3 (da) 1991-05-09 1992-04-23 Melatoninholdige sammensætninger

Country Status (11)

Country Link
US (2) US5500225A (da)
EP (1) EP0518468B1 (da)
JP (1) JPH072694A (da)
AT (1) ATE181670T1 (da)
DE (2) DE122007000073I1 (da)
DK (1) DK0518468T3 (da)
ES (1) ES2134789T3 (da)
GR (1) GR3031257T3 (da)
HK (1) HK1011932A1 (da)
LU (1) LU91378I2 (da)
NL (1) NL300306I1 (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6638963B1 (en) 1990-12-04 2003-10-28 Oregon Health And Science University Methods for treating circadian rhythm disorders
US5707652A (en) * 1990-12-04 1998-01-13 State Of Oregon Methods of treating circadian rhythm phase disorders
SG41955A1 (en) * 1992-04-07 1997-08-15 Neurim Pharma 1991 Use of melatonin for the manufacture of a medicament for the treatment of benign prostatic hyperplasia
IT1254995B (it) * 1992-06-24 1995-10-11 Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circandiani
US5385736A (en) * 1993-07-12 1995-01-31 Minnesota Mining And Manufacturing Company Transdermal melatonin delivery system
WO1995003043A1 (en) * 1993-07-26 1995-02-02 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University Sustained release oral compositions containing melatonin
FR2718020B1 (fr) * 1994-04-01 1996-05-31 Biotec Centre Sa Composition galénique mucoadhésive hétérofonctionnelle.
DE4443175A1 (de) * 1994-12-05 1996-06-13 Jenapharm Gmbh Neue pulsatile Arzneiform
SK284521B6 (sk) * 1995-02-01 2005-05-05 Neurim Pharmaceuticals (1991) Ltd. Použitie melatonínu na prípravu farmaceutického prostriedku
US6469044B1 (en) 1995-02-01 2002-10-22 Neurim Pharmaceuticals (1991) Ltd. Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies
US5688520A (en) * 1995-03-29 1997-11-18 Minnesota Mining And Manufacturing Company Transmucosal delivery of melatonin for prevention of migraine
ES2274527T3 (es) * 1995-06-07 2007-05-16 Veroscience Llc Metodo para la inhibicion de enfermedades neoplasicas en mamiferos.
US5792748A (en) * 1995-06-07 1998-08-11 The General Hospital Corporation Method for inhibiting neoplastic disease in mammals
DE19713141A1 (de) * 1996-03-29 1997-10-30 Labtec Gmbh Transdermales System mit Melatonin
DE19631084A1 (de) 1996-08-01 1998-02-05 Basf Ag Verwendung von (Meth)acrylsäure-Copolymeren zur Erhöhung der Permeabilität der Schleimhaut
DK0951842T3 (da) * 1999-01-20 2003-01-06 Nutricia Nv Ernæringsprodukt til et spædbarn
ES2284471T3 (es) 2000-01-05 2007-11-16 Neurim Pharmaceuticals (1991) Limited Metodo y formulacion para tratar la resistencia a antihipertensores y estados relacionados.
US20020119191A1 (en) * 2000-04-24 2002-08-29 Hitoo Nishino Pharmaceutical or food composition for treatment or prevention of brain edema
IL144900A (en) * 2001-08-14 2013-12-31 Neurim Pharma 1991 Melatonin and drugs containing it for use in the treatment of primary insomnia, and the manufacture of those drugs
US7365238B2 (en) * 2002-02-19 2008-04-29 The Procter And Gamble Company Absorbent article having a dehydration indicator
KR100501827B1 (ko) * 2002-09-24 2005-07-20 한국화학연구원 다층 코팅법을 이용한 멜라토닌 함유 타게팅 약물 전달 기구
US6703412B1 (en) * 2002-09-27 2004-03-09 Holly A. Rosenthal Method of treating sleeplessness with melatonin on an acute basis
TWI324604B (en) * 2003-06-18 2010-05-11 Novartis Ag New use of staurosporine derivatives
EP1715742A4 (en) * 2004-02-20 2009-06-17 Lifescape Biosciences Inc COMPOSITIONS AND METHODS FOR SLEEPING
EP2124907B1 (en) 2007-03-19 2018-05-30 Vita Sciences, Llc Transdermal patch and method for delivery of vitamin b12
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
US8691275B2 (en) 2011-01-28 2014-04-08 Zx Pharma, Llc Controlled-release melatonin compositions and related methods
US8808736B2 (en) 2011-02-11 2014-08-19 Zx Pharma, Llc Enteric coated multiparticulate controlled release peppermint oil composition and related methods
JP6025755B2 (ja) 2011-02-11 2016-11-16 ズィーエックス ファーマ，エルエルシー 多粒子ｌ−メントール製剤及びその関連する方法
US8911780B2 (en) 2011-02-11 2014-12-16 Zx Pharma, Llc Multiparticulate L-menthol formulations and related methods
US9572528B1 (en) 2012-08-06 2017-02-21 Los Angeles Biomedical Research Insitute at Harbor-UCLA Medical Center Monitor for SIDS research and prevention
FR3000896B1 (fr) 2013-01-14 2016-08-26 Philippe Perovitch Forme galenique pour l'administration de principe(s) actif(s) permettant l'induction acceleree du sommeil et/ou le traitement des troubles du sommeil
WO2014175916A1 (en) 2013-04-23 2014-10-30 Zx Pharma, Llc Enteric coated multiparticulate composition with proteinaceous subcoat
US10342779B2 (en) * 2014-10-13 2019-07-09 Worphmed Srl Anhydrous liquid melatonin composition
CN104546777A (zh) * 2014-12-16 2015-04-29 深圳翰宇药业股份有限公司 美乐托宁缓释组合物的制备方法、美乐托宁缓释片的制备方法
NL2015272B1 (en) * 2015-08-05 2017-05-02 Versailles B V Melatonin formulations and methods for preparation and use.
DK3337462T3 (da) * 2016-10-31 2020-10-12 Neurim Pharma 1991 Melatonin-minitabletter og fremgangsmåde til fremstilling heraf
US10849856B2 (en) 2016-10-31 2020-12-01 Neurim Pharmaceuticals Ltd. Melatonin mini-tablets and method of manufacturing the same
WO2019038586A1 (en) 2017-08-19 2019-02-28 Ftf Pharma Private Limited PHARMACEUTICAL COMPOSITION OF MELATONIN
CN113072479A (zh) * 2021-03-26 2021-07-06 罗田县新普生药业有限公司 一种从褪黑素结晶母液中提取褪黑素的方法
WO2023134856A1 (de) * 2022-01-13 2023-07-20 Paditz Ekkehart Säuglingsnahrung und verfahren zu deren herstellung

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5584503A (en) * 1978-12-19 1980-06-25 Teijin Ltd Preparing cellulose ester based selective permeable membrane
CA1151862A (en) * 1980-01-24 1983-08-16 Thomas J. Fogarty Flexible calibrator
US4855325A (en) * 1985-01-16 1989-08-08 Naftchi Nosrat E Treatment of mammals suffering from damage to the central nervous system
DE3466215D1 (en) * 1983-05-18 1987-10-22 Univ Monash The use of melatonin for the manufacture of a medicament
US4600723A (en) * 1983-05-18 1986-07-15 Monash University Method for minimizing disturbances in circadian rhythms of bodily performance and function
AU571922B2 (en) * 1984-01-26 1988-04-28 Schering Agrochemicals Limited Veterinary implants comprising melatonin and derivatives thereof
US4654361A (en) * 1986-01-27 1987-03-31 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Method of lowering intraocular pressure using melatonin
AU601736B2 (en) * 1986-05-23 1990-09-20 Sanofi Sante Nutrition Animale Sa Coated veterinary implants
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
WO1988006009A1 (en) * 1987-02-13 1988-08-25 Maurizio Graziosi System for making atoxic the shoe bottoms
US4855305A (en) * 1987-03-23 1989-08-08 Applied Medical Research Compositions and methods of effecting contraception utilizing melatonin
GB8727099D0 (en) * 1987-11-19 1987-12-23 Cellena Cell Eng A G Compositions containing melantonin/homologues
FR2630005B1 (fr) * 1988-04-14 1991-11-29 Goupil Jean Jacques Nouveau medicament anti-depresseur contenant du 5-methoxypsoralene
US4945103A (en) * 1989-01-17 1990-07-31 Michael Cohen Method of treating pre-menstrual syndrome
US5151446A (en) * 1989-09-25 1992-09-29 Northwestern University Substituted 2-amidotetralins as melatonin agonists and antagonists
JPH03145419A (ja) * 1989-10-31 1991-06-20 Shiseido Co Ltd 紫外線老化の防御薬剤

Also Published As

Publication number Publication date
NL300306I1 (nl) 2008-01-02
DE69229490D1 (de) 1999-08-05
US5498423A (en) 1996-03-12
GR3031257T3 (en) 1999-12-31
JPH072694A (ja) 1995-01-06
ES2134789T3 (es) 1999-10-16
HK1011932A1 (en) 1999-07-23
EP0518468A1 (en) 1992-12-16
DE69229490T2 (de) 2000-02-17
DE122007000073I1 (de) 2008-01-31
US5500225A (en) 1996-03-19
EP0518468B1 (en) 1999-06-30
LU91378I2 (en) 2008-01-23
ATE181670T1 (de) 1999-07-15

Similar Documents

Publication Publication Date Title
NL300306I1 (nl) Melatoninebevattende samenstellingen.
ATE76747T1 (de) Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
DK0735863T3 (da) Præparat indeholdende bromocriptin med accelereret frigørelse
NO20022014L (no) En fast oral kontrollert frigjorende doseringsform inneholdende hydrokodon
PT841903E (pt) Composicao farmaceutica oral contendo agentes activos antimicrobianos e pantoprazole com libertacao diferida
DK0713701T3 (da) 2-Brommelatonin til behandling af søvnforstyrrelser
DK0589893T3 (da) Anvendelse af et bakteriocin som antimikrobielt middel til fremstilling af et lægemiddel til behandl ing af maveforstyrrelser forbundet med helicobacter pylori
FI19991893A (fi) Säädellysti budesonidia vapauttava oraalisesti annettava koostumus ja budesonidin käyttö
DK515489A (da) Dispergerbar laegemiddelformulering
DE59410151D1 (de) Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
FI895520A0 (fi) Anti-aterosklerotiska diaryl foereningar.
NO924066D0 (no) Terapeutisk middel
ES2196167T3 (es) Composicion farmaceutica que contiene propionato de 3-(2,2,2-trimetilhidrazinio) y gamma-butirobetaina para el tratamiento de enfermedades cardiovasculares.
DK0457336T3 (da) Ny anvendelse af 4-carbamoyl-1-beta-D-ribofuranosylimidazolium-5-olat
IL98199A0 (en) Pharmaceutical compositions containing a derivative of substituted-l-valyl-l-prolinamide
IL111138A (en) Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
MX9203900A (es) Composicion farmaceutica que comprende derivados de acido benzimidazolin-2-oxo-1-carboxilico.
IL87867A0 (en) Preparation of pharmaceutical compositions containing a 2,6-diamino-pyridine derivatives
IL115861A (en) Pharmaceutical formulation for the treatment of infants in risk of sudden infant death syndrome
GR3037039T3 (en) Use of trimetazidine for the preparation of medicaments for the treatment of troubles due to the therapeutical use of immunosuppressants.
DE69131521T2 (de) Alpha-Ergocryptine enthaltende pharmazeutische Zusammensetzungen mit nervenschützender Wirkung
KR950016755A (ko) 간염의 예방 및 치료용 의약조성물
CZ176395A3 (en) The use of riluzol for preparing medicaments acceptable as antidotes against harmful effects of irradiation
DK1237552T3 (da) Kombination af lumilysergol og riluzol for forebyggelse og/eller behandling af motorisk neuron-sygdomme
ITMI913248A1 (it) Composizioni terapeutiche adatte per la somministrazione orale contenenti come principio attivo uno o piu' tioesteri del glutatione e procedimento per la preparazione dei suddetti principi attivi